Lumexa Imaging (NASDAQ:LMRI) Trading Down 12.7% – Here’s What Happened

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) traded down 12.7% during mid-day trading on Wednesday . The company traded as low as $8.91 and last traded at $9.1640. 211,733 shares traded hands during trading, a decline of 73% from the average session volume of 790,108 shares. The stock had previously closed at $10.50.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Barclays cut their target price on shares of Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Raymond James Financial upgraded shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective for the company in a research report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat, Lumexa Imaging has a consensus rating of “Strong Buy” and a consensus price target of $19.00.

Lumexa Imaging Stock Performance

The company has a 50-day simple moving average of $10.83.

Institutional Trading of Lumexa Imaging

Hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. bought a new stake in shares of Lumexa Imaging in the fourth quarter valued at about $36,000. Geode Capital Management LLC bought a new position in shares of Lumexa Imaging during the fourth quarter worth about $1,548,000. Seven Grand Managers LLC acquired a new stake in Lumexa Imaging in the 4th quarter valued at approximately $11,942,000. Goldman Sachs Group Inc. bought a new stake in Lumexa Imaging in the 4th quarter valued at approximately $18,870,000. Finally, TD Asset Management Inc bought a new stake in Lumexa Imaging in the 4th quarter valued at approximately $1,264,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).